| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010808 |
| Receipt No. | R000012650 |
| Official scientific title of the study | Study of the patient satisfaction in the self-reporting-questionnaire after the switching PPI from existing PPI to Esomeprazole in the reflux esophagitis patients |
| Date of disclosure of the study information | 2013/05/27 |
| Last modified on | 2017/06/22 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study of the patient satisfaction in the self-reporting-questionnaire after the switching PPI from existing PPI to Esomeprazole in the reflux esophagitis patients | |
| Title of the study (Brief title) | Study of the patient satisfaction in a self-reporting-questionnaire after the Esomeprazole switching | |
| Region |
|
|
| Condition | ||
| Condition | GERD | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Some reflux esophagitis patients remain with GERD symptom in spite of PPI treatment, and there are many patients who are not fully satisfied. Therefore, we switch PPI from other PPI to Esomeprazole for the RE patients who have GERD symptoms despite being administered other PPI, and we evaluate the change of the symptoms, the satisfaction level of patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Assessment of patient satisfaction in a self-reporting-questionnaire |
| Key secondary outcomes | Comparison of the effect according to the background factor |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Esomeplazole 20mg | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patient who fills everything the following
1) Man or woman who is 20 years old or older at the time of getting informed consent 2) Patient whom is given existing PPI, but one of the heartburn or acid reflux symptoms remains in 3) Patient that a document informed consent by the free intention of patients was gotten on enough understanding after having received enough explanation on participating in this study |
|||
| Key exclusion criteria | The patient in conflict with the following exclusion criteria is not enrolled
1) Patient with the drug allergy 2) Patient who complicated a serious heart disease, serious liver disease, renal function disorder, and malignant tumor |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Masahiko Inamori |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Gastroenterology Division |
| Address | 3-9 Fukuura, Kanagawa-ku, Yokohama, Japan |
| TEL | 045-787-2800 |
| Public contact | |
| Name of contact person | Masahiko Inamori |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Gastroenterology Division |
| Address | 3-9 Fukuura, Kanagawa-ku, Yokohama, Japan |
| TEL | 045-787-2800 |
| Homepage URL | |
| Sponsor | |
| Institute | Yokohama City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012650 |